SCHEMBL3592925

SCHEMBL3592925

CCOC(=O)c1c(C(=O)O)n(C)c2c1ccc1[nH]ncc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.43
USP2 O75604 1/20 0.43
PDE4D Q08499 2/20 0.38
KMT2A Q03164 3/20 0.38
ALDH1A1 P00352 3/20 0.38
MEN1 O00255 2/20 0.38
CLK1 P49759 1/20 0.37
CLK3 P49761 1/20 0.37
DYRK1A Q13627 1/20 0.37
GAA P10253 2/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
MAPT P10636 2/20 0.36
KDM5A P29375 1/20 0.36
KDM5B Q9UGL1 1/20 0.36
LMNA P02545 1/20 0.36
HPGD P15428 1/20 0.36
MAPK10 P53779 1/20 0.36
HSD17B10 Q99714 1/20 0.36
ADORA3 P0DMS8 1/20 0.36
ALOX5 P09917 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3601342 0.87 KDM4E (0.40) KDM4EPDE4DKMT2AALDH1A1MEN1
SCHEMBL3597421 0.75 ALDH1A1 (0.46) KDM4EKMT2AALDH1A1MEN1GAA
SCHEMBL29705922 0.73 AURKA (0.46) KDM4EPDE4DKMT2AALDH1A1MEN1
SCHEMBL5228664 0.72 ALDH1A1 (0.52) KDM4EPDE4DALDH1A1MAPTHPGD
SCHEMBL5232468 0.72 CCNA2 (0.46) KDM4EUSP2KMT2AALDH1A1MEN1
SCHEMBL6797679 0.71 CCNA2 (0.63) KDM4EPDE4DKMT2AALDH1A1MEN1
SCHEMBL3596935 0.71 CCNA2 (0.46) CCNA2CDK2CCNA1
SCHEMBL4816461 0.69 KDM4E (0.53) KDM4EKMT2AALDH1A1MEN1GAA
SCHEMBL27765520 0.69 KDM4E (0.61) KDM4EUSP2ALDH1A1GAASMN1; SMN2
SCHEMBL5229613 0.68 CCNA2 (0.57) KDM4EPDE4DALDH1A1SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2118102-B1 TRICYCLIC INDOLES AND (4,5-DIHYDRO) INDOLES NERVIANO MEDICAL SCIENCES SRL (IT) 2013-06-12 EP disclosed
US-8207180-B2 Tricyclic indoles and (4,5-dihydro) indoles NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-06-26 US disclosed
US-20100075998-A1 TRICYCLIC INDOLES AND (4,5-DIHYDRO) INDOLES NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2010-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100075998-A1 TRICYCLIC INDOLES AND (4,5-DIHYDRO) INDOLES CDC7, CDK7, CDK17 KDM4E 1753/4885USP2 3709/4885PDE4D 3018/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.